FP51-SL; a Powerful Ultra-low Refrigerated Circulator

Temperature control and sterilising

FP51-SL; a Powerful Ultra-low Refrigerated Circulator

25 May, 2007

Published over 19 years ago. See the latest and most current information on Temperature control and sterilising.

The Julabo Labortechnik GmbH HighTech series offers a new refrigerated circulator with innovative state-of-the art technology for more complex demands.

The model FP51-SL includes a self-optimising ICC (Intelligent Cascade Control) temperature control with temperature stability up to ±0.01 °C. The unit provide direct temperature measurement and control of the external system via an Pt100 sensor connection. The integrated early warning system for low liquid level (DBGM: 203 06 059.8) gives a warning, before a safety cut-off comes into effect. The circulator provides a powerful circulation pump system with electronically adjustable pump capacity (1.1 bar / 22-26 l/min).

The FP51-SL has a working temperature range of -51°C...+200°C and offers a cooling power of 2kW at +20°C in combination with 3kW heating power. Using the optional HST booster heater, the heating power can be increased by 6kW to a total of 9KW. An integrated programmer, with 6 x 60 program steps and a real-time clock, enables time-controlled temperature processes. Further features are 3-point calibration, large VFD-Display, Stakei connectors for solenoid valve and RS232/RS485 interface - analog interfaces (scalable) are available as option.

Latest News

Lab Asia 33.4 - August 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
From reacting to anticipating: how continuous monitoring is changing landfill emissions management
Explore more Arrow
Pollution Solutions Online
Oil pipeline decommissioning in Wales secures environmental safety for future generations
Explore more Arrow
Petro Online
Flash point testing aligned with petrochemical compliance requirements
Explore more Arrow
Chromatography Today
Unlock high-resolution analysis of therapeutic oligonucleotides
Explore more Arrow